You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Paediatric Oncology Therapeutics Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Children are affected by different forms of cancer than adults, there also exists a major difference between children and adults regarding treatment and development of new oncology therapies. The prominent variation is the concept of survival. With adult cancer patients, it is acceptable to look to immediate, 5 and 10-year survival rates, along with quality of life, for the best approximations of therapeutic success. On the other hand, a child cancer patient receives treatment to be cured. A typical difference between adult and pediatric oncologists is in treatment protocols; pediatric protocols are much more vigorous, often hitting patients “as hard as possible” to achieve a successful, long-term cure.
Market Analysis and Insights: Global Paediatric Oncology Therapeutics Market
The global Paediatric Oncology Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Paediatric Oncology Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Paediatric Oncology Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Paediatric Oncology Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Paediatric Oncology Therapeutics market.
Paediatric Oncology Therapeutics Breakdown Data by Type
By Treatment
Chemotherapy
Radiotheraphy
Tumor Surgery
Blood and Marrow Transplantation
Drug Therapy
By Indication
Leukemia
Central Nervous System (CNS) disorders
Bone Tumors
Inflammatory disorders
Respiratory disorders
Retinoblastoma
Paediatric Oncology Therapeutics Breakdown Data by Application
0-15 Years Old
15-19 Years Old
Based on regional and country-level analysis, the Paediatric Oncology Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Paediatric Oncology Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2016-2021.
The following players are covered in this report:
St Jude Children’s Research Hospital
St Louis Children’s Hospital
Monroe Carell Jr. Children’s Hospital at Vanderbilt
Birmingham Children’s Hospital
Royal Children’s Hospital
National Center for Child Health and Development
Dana-Dwek Children’s Hospital
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paediatric Oncology Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotheraphy
1.2.4 Tumor Surgery
1.2.5 Blood and Marrow Transplantation
1.2.6 Drug Therapy
1.3 Market by Application
1.3.1 Global Paediatric Oncology Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 0-15 Years Old
1.3.3 15-19 Years Old
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Paediatric Oncology Therapeutics Market Perspective (2016-2027)
2.2 Paediatric Oncology Therapeutics Growth Trends by Regions
2.2.1 Paediatric Oncology Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Paediatric Oncology Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Paediatric Oncology Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Paediatric Oncology Therapeutics Industry Dynamic
2.3.1 Paediatric Oncology Therapeutics Market Trends
2.3.2 Paediatric Oncology Therapeutics Market Drivers
2.3.3 Paediatric Oncology Therapeutics Market Challenges
2.3.4 Paediatric Oncology Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Paediatric Oncology Therapeutics Players by Revenue
3.1.1 Global Top Paediatric Oncology Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Paediatric Oncology Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Paediatric Oncology Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Paediatric Oncology Therapeutics Revenue
3.4 Global Paediatric Oncology Therapeutics Market Concentration Ratio
3.4.1 Global Paediatric Oncology Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Oncology Therapeutics Revenue in 2020
3.5 Paediatric Oncology Therapeutics Key Players Head office and Area Served
3.6 Key Players Paediatric Oncology Therapeutics Product Solution and Service
3.7 Date of Enter into Paediatric Oncology Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Paediatric Oncology Therapeutics Breakdown Data by Type
4.1 Global Paediatric Oncology Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Paediatric Oncology Therapeutics Forecasted Market Size by Type (2022-2027)

5 Paediatric Oncology Therapeutics Breakdown Data by Application
5.1 Global Paediatric Oncology Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Paediatric Oncology Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Paediatric Oncology Therapeutics Market Size (2016-2027)
6.2 North America Paediatric Oncology Therapeutics Market Size by Type
6.2.1 North America Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
6.3 North America Paediatric Oncology Therapeutics Market Size by Application
6.3.1 North America Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
6.4 North America Paediatric Oncology Therapeutics Market Size by Country
6.4.1 North America Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Paediatric Oncology Therapeutics Market Size (2016-2027)
7.2 Europe Paediatric Oncology Therapeutics Market Size by Type
7.2.1 Europe Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
7.3 Europe Paediatric Oncology Therapeutics Market Size by Application
7.3.1 Europe Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
7.4 Europe Paediatric Oncology Therapeutics Market Size by Country
7.4.1 Europe Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type
8.2.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application
8.3.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region
8.4.1 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Paediatric Oncology Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Paediatric Oncology Therapeutics Market Size (2016-2027)
9.2 Latin America Paediatric Oncology Therapeutics Market Size by Type
9.2.1 Latin America Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Paediatric Oncology Therapeutics Market Size by Application
9.3.1 Latin America Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Paediatric Oncology Therapeutics Market Size by Country
9.4.1 Latin America Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type
10.2.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application
10.3.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country
10.4.1 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Paediatric Oncology Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 St Jude Children’s Research Hospital
11.1.1 St Jude Children’s Research Hospital Company Details
11.1.2 St Jude Children’s Research Hospital Business Overview
11.1.3 St Jude Children’s Research Hospital Paediatric Oncology Therapeutics Introduction
11.1.4 St Jude Children’s Research Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.1.5 St Jude Children’s Research Hospital Recent Development
11.2 St Louis Children’s Hospital
11.2.1 St Louis Children’s Hospital Company Details
11.2.2 St Louis Children’s Hospital Business Overview
11.2.3 St Louis Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.2.4 St Louis Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.2.5 St Louis Children’s Hospital Recent Development
11.3 Monroe Carell Jr. Children’s Hospital at Vanderbilt
11.3.1 Monroe Carell Jr. Children’s Hospital at Vanderbilt Company Details
11.3.2 Monroe Carell Jr. Children’s Hospital at Vanderbilt Business Overview
11.3.3 Monroe Carell Jr. Children’s Hospital at Vanderbilt Paediatric Oncology Therapeutics Introduction
11.3.4 Monroe Carell Jr. Children’s Hospital at Vanderbilt Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.3.5 Monroe Carell Jr. Children’s Hospital at Vanderbilt Recent Development
11.4 Birmingham Children’s Hospital
11.4.1 Birmingham Children’s Hospital Company Details
11.4.2 Birmingham Children’s Hospital Business Overview
11.4.3 Birmingham Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.4.4 Birmingham Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.4.5 Birmingham Children’s Hospital Recent Development
11.5 Royal Children’s Hospital
11.5.1 Royal Children’s Hospital Company Details
11.5.2 Royal Children’s Hospital Business Overview
11.5.3 Royal Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.5.4 Royal Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.5.5 Royal Children’s Hospital Recent Development
11.6 National Center for Child Health and Development
11.6.1 National Center for Child Health and Development Company Details
11.6.2 National Center for Child Health and Development Business Overview
11.6.3 National Center for Child Health and Development Paediatric Oncology Therapeutics Introduction
11.6.4 National Center for Child Health and Development Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.6.5 National Center for Child Health and Development Recent Development
11.7 Dana-Dwek Children’s Hospital
11.7.1 Dana-Dwek Children’s Hospital Company Details
11.7.2 Dana-Dwek Children’s Hospital Business Overview
11.7.3 Dana-Dwek Children’s Hospital Paediatric Oncology Therapeutics Introduction
11.7.4 Dana-Dwek Children’s Hospital Revenue in Paediatric Oncology Therapeutics Business (2016-2021)
11.7.5 Dana-Dwek Children’s Hospital Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 101